Trials / Completed
CompletedNCT06471218
Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Evaluation of the Efficacy and Safety of Multiple Subcutaneous Injections of SHR-1918 in Patients With Hyperlipidemia in Poor Control: a Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trials
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efficacy and safety of multiple subcutaneous injections of SHR-1918 in patients with hyperlipidemia in poor control: a multicenter, randomized, double-blind, placebo-controlled phase II clinical trials
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-1918; SHR-1918 Placebo | SHR-1918/SHR-1918 Placebo,two administration |
Timeline
- Start date
- 2024-07-02
- Primary completion
- 2025-05-16
- Completion
- 2025-05-16
- First posted
- 2024-06-24
- Last updated
- 2026-02-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06471218. Inclusion in this directory is not an endorsement.